These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 6381384)

  • 1. Autologous bone marrow transplantation for acute leukemia using transplant chemopurified with metabolite of oxazaphosphorines (ASTA Z 7557, INN mafosfamide). First clinical results.
    Hervé P; Cahn JY; Plouvier E; Flesch M; Tamayo E; Leconte des Floris R; Peters A
    Invest New Drugs; 1984; 2(2):245-52. PubMed ID: 6381384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autologous bone marrow transplantation using marrow incubated with Asta Z 7557 in adult acute leukemia.
    Gorin NC; Douay L; Laporte JP; Lopez M; Mary JY; Najman A; Salmon C; Aegerter P; Stachowiak J; David R
    Blood; 1986 May; 67(5):1367-76. PubMed ID: 3516254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toxicity of ASTA Z 7557 (INN mafosfamide) to normal- and leukemic stem cells: implications for autologous bone marrow transplantation.
    Hagenbeek A; Martens AC
    Invest New Drugs; 1984; 2(2):237-43. PubMed ID: 6381383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential sensitivity of adherent CFU-blast, CFU-mix, BFU-E, and CFU-GM to mafosfamide: implications for adjusted dose purging in autologous bone marrow transplantation.
    Carlo-Stella C; Mangoni L; Almici C; Garau D; Craviotto L; Piovani G; Caramatti C; Rizzoli V
    Exp Hematol; 1992 Mar; 20(3):328-33. PubMed ID: 1568448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ASTA Z 7557 (INN mafosfamide) for the in vitro treatment of human leukemic bone marrows.
    Douay L; Gorin NC; Laporte JP; Lopez M; Najman A; Duhamel G
    Invest New Drugs; 1984; 2(2):187-90. PubMed ID: 6381382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro chemosensitivity of leukemic progenitor cells (AML-CFU) to a combination of mafosfamide lysine (ASTA-Z 7654) and etoposide (VP16-213).
    Deconinck E; Tamayo E; Hervé P
    Bone Marrow Transplant; 1990 Jan; 5(1):13-8. PubMed ID: 2297586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Difference in kinetics of hematopoietic reconstitution between ALL and ANLL after autologous bone marrow transplantation with marrow treated in vitro with mafosfamide (ASTA Z 7557).
    Douay L; Laporte JP; Mary JY; Lopez M; Lemonnier MP; Stachowiak J; Benitez O; Deloux J; Najman A; Salmon C
    Bone Marrow Transplant; 1987 Jun; 2(1):33-43. PubMed ID: 3332155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of mafosfamide (ASTA-Z-7654) on the clonogenic cells in precursor-B acute lymphoblastic leukaemia: significance for ex vivo purging of bone marrow for autologous transplantation.
    Makrynikola V; Kabral A; Bradstock KF
    Bone Marrow Transplant; 1991 Nov; 8(5):351-5. PubMed ID: 1768969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preclinical studies of the combination of mafosfamide (Asta-Z 7654) and etoposide (VP-16-213) for purging leukemic autologous marrow.
    Tamayo E; Hervé P
    Exp Hematol; 1988 Feb; 16(2):97-101. PubMed ID: 3276544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Normal hematopoietic reconstitution following ASTA-Z 7557-purged grafts in the absence of in vitro CFU-GM colony growth.
    Nagler A; Mumcuoglu M; Naparstek E; Or R; Gan S; Slavin S
    Leuk Res; 1993 Jan; 17(1):61-7. PubMed ID: 8429681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Bone marrow autotransplantation in acute myeloblastic leukemia in its first complete remission. The clinical results in 41 patients].
    Tomás JF; Gómez-García de Soria V; Pinilla I; Lamana M; Figuera A; Arranz R; Cámara R; Fernández-Villalta MJ; Alegre A; Fernández-Rañada JM
    Med Clin (Barc); 1997 Feb; 108(6):201-6. PubMed ID: 9102484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of recombinant human stem cell factor on mafosfamide-treated bone marrow clonogenic cells.
    Carlo-Stella C; Mangoni L; Almici C; Caramatti C; Rizzoli V
    Stem Cells; 1993 Jul; 11 Suppl 2():170-4. PubMed ID: 7691323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Importance of marrow dose on posttransplant outcome in acute leukemia: models derived from patients autografted with mafosfamide-purged marrow at a single institution.
    Gorin NC; Labopin M; Laporte JP; Douay L; Lopez M; Lesage S; Fouillard L; Isnard F; Jouet JP; Bellal N; Perot C; Van Den Akker J; Bauters F; Najman A
    Exp Hematol; 1999 Dec; 27(12):1822-30. PubMed ID: 10641600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. No preferential sensitivity of clonogenic AML cells to ASTA-Z-7557.
    Kluin-Nelemans HC; Martens AC; Löwenberg B; Hagenbeek A
    Leuk Res; 1984; 8(4):723-8. PubMed ID: 6590937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incubation of autologous bone marrow graft with ASTA Z 7557: comparative studies of hematological reconstitution after purged or nonpurged bone marrow transplantation.
    Beaujean F; Hartmann O; Pico J; Parmentier C; Hayat M; Lemerle J; Duédari N
    Pediatr Hematol Oncol; 1987; 4(2):105-15. PubMed ID: 3152918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacologic bone marrow purging: is there any place for etoposide? In vitro comparison with mafosfamide.
    Olivieri A; Poloni A; Montanari M; Cantori I; Corvatta L; Masia MC; Curzi L; Mancini S; Leoni P
    J Hematother; 1997 Apr; 6(2):137-44. PubMed ID: 9131443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of recombinant cytokines for enhancing immunohematopoietic reconstitution following bone marrow transplantation. II. The influence of lymphokines on CFU-GM colonies from human untreated, ASTA-Z or Campath-1M treated bone marrow.
    Mumcuoglu M; Naparstek E; Slavin S
    Bone Marrow Transplant; 1990 Mar; 5(3):153-8. PubMed ID: 2184907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Collagen gel cultures for detection of spared hematopoietic progenitors in Asta Z 7557 purged human marrows.
    Praloran V; Dobo I; Garand R; Klausman M; Naud MF; Milpied N; Harousseau JL
    Leukemia; 1990 Apr; 4(4):282-6. PubMed ID: 2366583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ex vivo expansion of normal progenitor cells from acute myeloid leukemia cell-contaminated CD34+ peripheral blood progenitor cells after mafosfamide purging.
    Stilz R; Grünebach F; Bader P; Vogel W; Kanz L; Brugger W; Scheding S
    J Hematother Stem Cell Res; 2001 Dec; 10(6):777-85. PubMed ID: 11798504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation of occult clonogenic leukemia drug sensitivity with relapse after autologous bone marrow transplantation.
    Miller CB; Zehnbauer BA; Piantadosi S; Rowley SD; Jones RJ
    Blood; 1991 Aug; 78(4):1125-31. PubMed ID: 1868244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.